Patients with coronavirus disease 2019 (COVID-19) usually suffer from post-acute sequelae
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long-…

… of patients with idiopathic pulmonary fibrosis (IPF) continues … collaborations, and directions
for future research. The workshop … a basis for directing future research and strategic planning …

… However, although these results herald a new era in treatment of idiopathic pulmonary
fibrosis, the specialty now faces formidable challenges in moving forward. Paradoxically, the …

… In this paper, we summarize the most recent advances in pharmacological treatment of
IPF and discuss challenges and future perspectives in the management of this devastating …

… Future research is required to have a better understanding of the natural history of pulmonary
fibrosis post-COVID, as well as its pathogenesis and clinical and psychosocial impact on …

… Here we summarise new therapeutic attempts and potential future approaches to treat this
… Accurate diagnosis in IPF remains a challenge and the current gold standard of performing a …

… Finally, we will discuss challenges and future directions … Idiopathic pulmonary fibrosis (IPF)
is the most common of the … Finally, we will discuss challenges and future directions related …

… Echocardiography on these patients is technically challenging because suboptimal images
are … Clinically, cor pulmonale is a challenging diagnosis since the signs and symptoms are …

… Idiopathic pulmonary fibrosis (IPF) is a fatal age-associated … of the human disease are
major challenges. As ageing is a major risk … In addition, we discuss current and potential future …

… Medicine has advanced in the past only when assumptions about diseases and treatments
were examined critically; we must continue to challenge our assumptions about IPF and …